Cite
HARVARD Citation
Sun, Y. et al. (2016). Abiraterone acetate for metastatic castration‐resistant prostate cancer after docetaxel failure: A randomized, double‐blind, placebo‐controlled phase 3 bridging study. International journal of urology. pp. 404-411. [Online].